Literature DB >> 23534501

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.

S M Nguyen1, D H Thamm2, D M Vail3, C A London1.   

Abstract

In veterinary medical oncology, there is currently no standardized protocol for assessing response to therapy in solid tumours. The lack of such a formalized guideline makes it challenging to critically compare outcome measures across various treatment protocols. The Veterinary Cooperative Oncology Group (VCOG) membership consensus document presented here is based on the recommendations of a subcommittee of American College of Veterinary Internal Medicine (ACVIM) board-certified veterinary oncologists. This consensus paper has used the human response evaluation criteria in solid tumours (RECIST v1.1) as a framework to establish standard procedures for response assessment in canine solid tumours that is meant to be easy to use, repeatable and applicable across a variety of clinical trial structures in veterinary oncology. It is hoped that this new canine RECIST (cRECIST v1.0) will be adopted within the veterinary oncology community and thereby facilitate the comparison of current and future treatment protocols used for companion animals with cancer.
© 2013 Blackwell Publishing Ltd.

Entities:  

Keywords:  chemotherapy; clinical trials; comparative oncology; imaging; oncology; small animal

Mesh:

Year:  2013        PMID: 23534501     DOI: 10.1111/vco.12032

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  77 in total

Review 1.  Defining the Value of a Comparative Approach to Cancer Drug Development.

Authors:  Amy K LeBlanc; Christina N Mazcko; Chand Khanna
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

2.  Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.

Authors:  T Laver; C A London; D M Vail; B J Biller; J Coy; D H Thamm
Journal:  Vet Comp Oncol       Date:  2017-06-15       Impact factor: 2.613

3.  Evaluation of radiographs for the detection of sublumbar lymphadenopathy in dogs.

Authors:  Megan C Murphy; Martin Sullivan; Barbara J Gomes; Ada Kaczmarska; Gawain J C Hammond
Journal:  Can Vet J       Date:  2020-07       Impact factor: 1.008

4.  Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials.

Authors:  Rebecca A Packer; John H Rossmeisl; Michael S Kent; John F Griffin; Christina Mazcko; Amy K LeBlanc
Journal:  Vet Radiol Ultrasound       Date:  2018-03-09       Impact factor: 1.363

5.  KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.

Authors:  Cheryl A London; Heather L Gardner; Sarah Rippy; Gerald Post; Krista La Perle; Linda Crew; Lori Lopresti-Morrow; Andrew J Garton; Gerald McMahon; Theresa M LaVallee; Richard Gedrich
Journal:  Clin Cancer Res       Date:  2016-11-04       Impact factor: 12.531

6.  Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique.

Authors:  Andrew J Leffler; Eric T Hostnik; Emma E Warry; Gregory G Habing; Danelle M Auld; Eric M Green; Wm Tod Drost
Journal:  Vet Radiol Ultrasound       Date:  2018-07-10       Impact factor: 1.363

7.  Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors.

Authors:  Cheryl A London; Jaime Acquaviva; Donald L Smith; Manuel Sequeira; Luisa Shin Ogawa; Heather L Gardner; Louis Feo Bernabe; Misty D Bear; Sandra A Bechtel; David A Proia
Journal:  Clin Cancer Res       Date:  2018-08-31       Impact factor: 12.531

Review 8.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

9.  In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers.

Authors:  Sita S Withers; Daniel York; Eric Johnson; Sami Al-Nadaf; Katherine A Skorupski; Carlos O Rodriguez; Jenna H Burton; Teri Guerrero; Kriste Sein; Luke Wittenburg; Robert B Rebhun
Journal:  Vet Comp Oncol       Date:  2018-08-08       Impact factor: 2.613

10.  Quantification of plasma cell-free DNA levels in dogs with various tumors.

Authors:  Michihito Tagawa; Genya Shimbo; Hisashi Inokuma; Kazuro Miyahara
Journal:  J Vet Diagn Invest       Date:  2019-10-04       Impact factor: 1.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.